1 Min Read
Feb 27 (Reuters) - Helix Biopharma Corp
* Helix Biopharma Corp. Announces licence for worldwide right to anti-CEACAM6 antibody from the Government of Canada Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.